Chang-ying Xing
No. 300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial.
Journal: Journal of integrative medicine
Published: August 24, 2020
Kidney-Replenishing Herb Induces SOCS-3 Expression via ERK/MAPK Pathway and Improves Growth of the First-Trimester Human Trophoblast Cells.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: February 09, 2017
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial.
Journal: International urology and nephrology
Published: October 21, 2016
Detection and evaluation of renal biomarkers in a swine model of acute myocardial infarction and reperfusion.
Journal: International journal of clinical and experimental pathology
Published: April 25, 2015
The relationship between AASI and arterial atherosclerosis in ESRD patients.
Journal: Renal failure
Published: September 26, 2014
Dramatic alteration of the skull in a uremic patient with leontiasis ossea.
Journal: Internal medicine (Tokyo, Japan)
Published: September 02, 2014
Treatment of chronic primary glomerulopathy patients of Shen deficiency and dampness heat syndrome by yishen qingli granule combined low-dose Tripterygium wilfordii multiglycoside tablet: a clinical efficacy observation
Journal: Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
Published: February 13, 2014
Efficacy and safety of Changfu peritoneal dialysis solution: a multi-center prospective randomized controlled trial.
Journal: Chinese medical journal
Published: November 19, 2013
Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis.
Journal: Experimental and therapeutic medicine
Published: October 30, 2013
Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: July 06, 2013
The efficacy and safety of continuous erythropoietin receptor activator in dialytic patients with chronic renal anemia: an open, randomized, controlled, multi-center trial
Journal: Zhonghua nei ke za zhi
Published: September 05, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026